Trials / Conditions / Non-ischemic Cardiomyopathy

Non-ischemic Cardiomyopathy

29 registered clinical trials studyying Non-ischemic Cardiomyopathy — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Longitudinal Validation of CIRC Technologies NCT07081711	The Cleveland Clinic	—
Recruiting	Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead NCT06920030	Berlin Heals GmbH	N/A
Completed	Metabolomic Profiling in Ischemic and Non-Ischemic Cardiomyopathy Patients With Ventricular Arrhythmias NCT07507539	Muhammed Heja Geçit	—
Recruiting	Cardiac RadiothErapy For hEart faiLure NCT06661876	Universitaire Ziekenhuizen KU Leuven	N/A
Enrolling By Invitation	Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat NCT06635863	Roderick Tung	Phase 4
Recruiting	Non-ischemic Cardiomyopathy Registry, Biobank and Imaging Data Repository NCT07110818	Montreal Heart Institute	—
Recruiting	Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function NCT06243653	Samsung Medical Center	—
Active Not Recruiting	Assessment of Combined CCM and ICD Device in HFrEF NCT05855135	Impulse Dynamics	N/A
Recruiting	Cardiovascular Multimodality Imaging Study NCT06610019	Montefiore Medical Center	—
Recruiting	LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB NCT05572957	The First Affiliated Hospital with Nanjing Medical University	N/A
Recruiting	Development of CIRC Technologies NCT05654272	The Cleveland Clinic	—
Recruiting	DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Resea NCT04265040	University Hospital Heidelberg	—
Completed	The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Fa NCT04325594	The Research-Clinical Center for Cardiac Surgery and Transplantology LLP	Phase 1 / Phase 2
Terminated	Serial Infusions of Allogeneic Mesenchymal Stem Cells in Cardiomyopathy Patients With Left Ventricular Assist NCT03925324	Medstar Health Research Institute	Phase 2
Terminated	Electrogram-Guided Myocardial Advanced Phenotyping NCT03293381	University of Pennsylvania	—
Unknown	Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Fail NCT03830957	Rajaie Cardiovascular Medical and Research Center	N/A
Recruiting	Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Pa NCT06607471	Scientific Institute San Raffaele	—
Completed	Sudden Death Stratification NCT04607265	Hospices Civils de Lyon	—
Suspended	Left Cardiac Sympathetic Denervation for Cardiomyopathy Feasibility Pilot Study NCT03071653	University of Cape Town	Phase 2
Completed	Inflammatory/Familial Dilated Cardiomyopathy: Is There a Link to Autoimmune Diseases? TP9a NCT03090425	Philipps University Marburg	—
Completed	Development of an Evidenced-Based Tool for Prediction of Sudden Death in Patients With Non-Ischemic Cardiomyop NCT02657967	NYU Langone Health	—
Terminated	A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure NCT02346422	Celladon Corporation	Phase 1 / Phase 2
Completed	Early MRI Detection of Myocardial Deterioration as a Preventive, Disease Staging, and Prognostic Biomarker in NCT03509441	Stanford University	—
Terminated	AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure NCT01966887	Assistance Publique - Hôpitaux de Paris	Phase 2
Withdrawn	Study of the Acute Effects of Triheptanoin in Heart Failure NCT01787851	University of Texas Southwestern Medical Center	Phase 1 / Phase 2
Terminated	Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy NCT01935622	Virginia Commonwealth University	Phase 2
Completed	A Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure NCT01643330	Celladon Corporation	Phase 2
Unknown	Use of Beta-agonists in Stable Severe Congestive Heart Failure NCT01447069	Rabin Medical Center	N/A
Recruiting	Cardiac Magnetic Resonance for Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy NCT07351838	Chinese Academy of Medical Sciences, Fuwai Hospital	—